Parkway Life REIT target raised to $2.60 by CIMB

Stock Name: ParkwayLife Reit
Company Name: PARKWAYLIFE REIT

Research House: CIMB

Price Call: BUY

Target Price: 2.60

SINGAPORE (Jan 28): CIMB has raised its price target for Parkway Life REIT to $2.60 from $2.53 after increasing its distribution per unit estimates to factor in gains from the property trust's recent divestment of seven nursing homes in Japan.

The $13.5-million gain will be distributed to investors in 2015 once the sales proceeds are repatriated from Japan.

With the additional payout, Parkway Life's total distribution for 2015 could amount to 13.7 cents a unit, according to CIMB analyst Tan Xuan, who has an "add" rating on the stock.

Parkway Life REIT kept at 'buy' with $2.66 target price by DBS

Stock Name: ParkwayLife Reit
Company Name: PARKWAYLIFE REIT

Research House: DBS Vickers

Price Call: BUY

Target Price: 2.66

SINGAPORE (Dec 4): DBS Group Research is maintaining its "buy" call on Parkway Life REIT, with a price target of $2.66.

In a Dec 4 report, analysts Derek Tan and Andy Sim says P-Life REIT offers a good balance of visibility and growth. Asset recycling in Japan and future acquisitions are also potential re-rating catalysts for the stock.

P-Life REIT derives its income from a diversified base of healthcare-related properties with Singapore hospitals contributing 64% of revenues, Japan at 36% and Malaysia at less than 1%.